Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Zhang, Weiying ^a   Lu, Zhanping ^a   Kong, Guangyao ^a   Gao, Yuen ^a   Wang, Tao ^a   Wang, Qi ^a   Cai, Na ^a   Wang, Honghui ^a   Liu, Fabao ^a   Ye, Lihong ^a   Zhang, Xiaodong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

HBx; HBXIP; Hepatocarcinogenesis; Hepatoma; miR 520b; Survivin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DNA; EDOXUDINE; HEPATITIS B VIRUS X PROTEIN; HEPATITIS B X INTERACTING PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 520B; ONCOPROTEIN; SURVIVIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS PROTEIN; BIRC5 PROTEIN, HUMAN; HBXIP PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MIRN520 MICRORNA, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SP1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

3T3 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; HEPATOCYTE TRANSPLANTATION; HEPATOMA CELL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LUCIFERASE ASSAY; MOUSE; MTT ASSAY; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; COMPLICATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HEPACIVIRUS; HEPATITIS B; HOST PATHOGEN INTERACTION; LIVER NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

HEPATITIS B VIRUS; MUS; MUS MUSCULUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; DNA METHYLATION; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS B; HOST-PATHOGEN INTERACTIONS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MICE; MICE, NUDE; MICE, TRANSGENIC; MICRORNAS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 84902080046     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-128     Document Type: Article

References (49)

1. Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, Qiu G, Xie K. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Int J Oncol 2005, 26:467-473.
2. Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway. Mol Cancer Res 2004, 2:159-169.
3. Wu JY, Zhou ZY, Judd A, Cartwright CA, Robinson WS. The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase. Cell 1990, 63:687-695. 10.1016/0092-8674(90)90135-2, 2225072.
4. Zhang T, Zhang J, You X, Liu Q, Du Y, Gao Y, Shan C, Kong G, Wang Y, Yang X, Ye L, Zhang X. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology 2012, 56:2051-2059. 10.1002/hep.25899, 22707013.
5. You X, Liu F, Zhang T, Lv N, Liu Q, Shan C, Du Y, Kong G, Wang T, Ye L, Zhang X. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells. Oncogene 2013, 33:449-460.
6. You X, Liu F, Zhang T, Li Y, Ye L, Zhang X. Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis 2013, 34:1644-1652. 10.1093/carcin/bgt089, 23471881.
7. Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology 2012, 55:108-120. 10.1002/hep.24675, 21932402.
8. Arzumanyan A, Sambandam V, Clayton MM, Choi SS, Xie G, Diehl AM, Yu DY, Feitelson MA. Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Res 2012, 72:5912-5920. 10.1158/0008-5472.CAN-12-2329, 3521045, 22986746.
9. Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C, Wang D, Sun Y, Hu G, Lang Z, Huang C, Yang X. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 2004, 39:318-324. 10.1002/hep.20076, 14767984.
10. Kim YC, Song KS, Yoon G, Nam MJ, Ryu WS. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene 2001, 20:16-23. 10.1038/sj.onc.1203840, 11244501.
11. Lu X, Lee M, Tran T, Block T. High level expression of apoptosis inhibitor in hepatoma cell line expressing Hepatitis B virus. Int J Med Sci 2005, 2:30-35. 1142222, 15968337.
12. Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol 2005, 77:374-381. 10.1002/jmv.20466, 16173017.
13. Cha MY, Kim CM, Park YM, Ryu WS. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Hepatology 2004, 39:1683-1693. 10.1002/hep.20245, 15185310.
14. Zhou XL, Qin XR, Zhang XD, Ye LH. Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/beta-catenin signaling. Acta Pharmacol Sin 2010, 31:202-210. 10.1038/aps.2009.200, 20139903.
15. Zhou X, Liu Y, You J, Zhang H, Zhang X, Ye L. Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett 2008, 270:312-327. 10.1016/j.canlet.2008.05.028, 18710790.
16. Melegari M, Scaglioni PP, Wands JR. Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 1998, 72:1737-1743. 109461, 9499022.
17. Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150:1196-1208. 10.1016/j.cell.2012.07.032, 3517996, 22980980.
18. Liu S, Li L, Zhang Y, Zhao Y, You X, Lin Z, Zhang X, Ye L. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells. J Biol Chem 2012, 287:30228-30239. 10.1074/jbc.M112.343947, 3436276, 22740693.
19. Hu N, Zhang J, Cui W, Kong G, Zhang S, Yue L, Bai X, Zhang Z, Zhang W, Zhang X, Ye L. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem 2011, 286:13714-13722. 10.1074/jbc.M110.204131, 3075715, 21343296.
20. Wang FZ, Sha L, Zhang WY, Wu LY, Qiao L, Li N, Zhang XD, Ye LH. Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacol Sin 2007, 28:431-438. 10.1111/j.1745-7254.2007.00531.x, 17303008.
21. Cui W, Zhao Y, Shan C, Kong G, Hu N, Zhang Y, Zhang S, Zhang W, Zhang X, Ye L. HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-kappaB signaling to protect breast cancer cells from complement attack. FEBS Lett 2012, 586:766-771. 10.1016/j.febslet.2012.01.039, 22293503.
22. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 2003, 22:2729-2740. 10.1093/emboj/cdg263, 156760, 12773388.
23. Wen Y, Golubkov VS, Strongin AY, Jiang W, Reed JC. Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem 2008, 283:2793-2803. 10.1074/jbc.M708419200, 18032378.
24. Fujii R, Zhu C, Wen Y, Marusawa H, Bailly-Maitre B, Matsuzawa S, Zhang H, Kim Y, Bennett CF, Jiang W, Reed JC. HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 2006, 66:9099-9107. 10.1158/0008-5472.CAN-06-1886, 16982752.
25. Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, Akanuma M, Kondo Y, Kang YJ, Kishikawa T, Kato N, Xie Z, Zhang WJ, Yoshida H, Omata M, Nepveu A, Koike K. MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2011, 2:338.
26. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017. 10.1016/j.cell.2009.04.021, 2722880, 19524505.
27. Cui W, Zhang Y, Hu N, Shan C, Zhang S, Zhang W, Zhang X, Ye L. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46. Cancer Biol Ther 2010, 10:232-241. 10.4161/cbt.10.3.12277, 20574151.
28. Zhang W, Kong G, Zhang J, Wang T, Ye L, Zhang X. MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1. PLoS One 2012, 7:e31450. 10.1371/journal.pone.0031450, 3272016, 22319632.
29. Zhang WY, Cai N, Ye LH, Zhang XD. Transformation of human liver L-O2 cells mediated by stable HBx transfection. Acta Pharmacol Sin 2009, 30:1153-1161. 10.1038/aps.2009.99, 19578387.
30. Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J, Alaoui-Jamali MA. Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem 2001, 276:14124-14132.
31. Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003, 37:764-770. 10.1053/jhep.2003.50146, 12668968.
32. Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006, 147:58-66. 10.1016/j.lab.2005.10.003, 16459163.
33. Ye H, Zhang C, Wang BJ, Tan XH, Zhang WP, Teng Y, Yang X. Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice. Oncogene 2013, doi: 10.1038/onc.2013.468. [Epub ahead of print].
34. Djos A, Martinsson T, Kogner P, Caren H. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma. Mol Cancer 2012, 11:40. 10.1186/1476-4598-11-40, 3493266, 22695170.
35. Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol Cancer 2011, 10:124. 10.1186/1476-4598-10-124, 3193026, 21962230.
36. Regel I, Eichenmuller M, Joppien S, Liebl J, Haberle B, Muller-Hocker J, Vollmar A, von Schweinitz D, Kappler R. IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors. Mol Cancer 2012, 11:9. 10.1186/1476-4598-11-9, 3349592, 22401581.
37. Cho S, Lee JH, Cho SB, Yoon KW, Park SY, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma. Pathol Int 2010, 60:203-211. 10.1111/j.1440-1827.2009.02507.x, 20403046.
38. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013, 25:439-446. 10.1016/j.cellsig.2012.10.013, 23124077.
39. Zhang Y, Zhao Y, Li H, Li Y, Cai X, Shen Y, Shi H, Li L, Liu Q, Zhang X, Ye L. The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells. J Biol Chem 2013, 288:18961-18974. 10.1074/jbc.M113.458638, 23667255.
40. Liu Q, Bai X, Li H, Zhang Y, Zhao Y, Zhang X, Ye L. The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells. Int J Cancer 2013, 133:1310-1322. 10.1002/ijc.28154, 23494474.
41. Yue L, Li L, Liu F, Hu N, Zhang W, Bai X, Li Y, Zhang Y, Fu L, Zhang X, Ye L. The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells. Carcinogenesis 2013, 34:927-935. 10.1093/carcin/bgs399, 3616668, 23291272.
42. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 2011, 6:e19518. 10.1371/journal.pone.0019518, 3088678, 21573166.
43. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
44. Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL, Ferry N, Weinberg MS, Arbuthnot P. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther 2006, 13:411-421. 10.1016/j.ymthe.2005.10.013, 16337206.
45. Wang FZ, Sha L, Ye LH, Zhang XD. Promotion of cell proliferation by HBXIP via upregulation of human telomerase reverse transcriptase in human mesenchymal stem cells. Acta Pharmacol Sin 2008, 29:83-89. 10.1111/j.1745-7254.2008.00729.x, 18158869.
46. Zhang H, Wu LY, Zhang S, Qiu LY, Li N, Zhang X, Zhang XZ, Shan CL, Ye LH, Zhang XD. Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV. J Biomed Biotechnol 2009, 2009:289068. 2738860, 19746176.
47. Carvalho A, Carmena M, Sambade C, Earnshaw WC, Wheatley SP. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J Cell Sci 2003, 116:2987-2998. 10.1242/jcs.00612, 12783991.
48. Shan C, Xu F, Zhang S, You J, You X, Qiu L, Zheng J, Ye L, Zhang X. Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Res 2010, 20:563-575. 10.1038/cr.2010.49, 20386571.
49. Wei W, Huang W, Pan Y, Zhu F, Wu J. Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras. Cancer Lett 2006, 244:119-128. 10.1016/j.canlet.2005.12.008, 16569476.